e-SPACE Heart Failure 2022
Published: 19 October 2022
-
Views:
17616
-
Likes:
7
-
Views:
17616
-
Likes:
7
-
1h 1m 14sPart 1 | Session 1 Plenary Session 1: Implementing the 4 foundational therapies in clinical practice John J Atherton, Piotr Ponikowski, Mark Petrie, Gianluigi Savarese, Kieran Docherty
-
32m 48sPart 1 | Session 2 Meet the expert: Emerging evidence across the spectrum of heart failure: new insights from the deliver trial (Supported by an educational grant from AstraZeneca) John JV McMurray, Rudolf A. de Boer
-
1h 22sPart 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1) Yuhui Zhang, David Sim, Giuseppe Rosano, Vijay Chopra, Béla Merkely, A John Camm
-
36m 21sPart 1 | Session 4 Meet the expert: SGLT2 inhibition in patients with HFpEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Maurizio Volterrani, Anja Sandek
-
29m 54s
-
1h 1m 19sPart 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations Philippe Gabriel Steg, Shelley Zieroth, Milton Packer, Muthiah Vaduganathan, Cecilia Bahit , Subodh Verma
-
41m 26sPart 1 | Session 7 Satellite Symposium: SGLT2 inhibition as foundational heart failure therapy: have we changed our practices? (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Andrew JS Coats, Shelley Zieroth, Stefan Anker, Daniela Tomasoni, Clara Saldarriaga
-
53m 32sPart 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2) Giuseppe Galati, Altamash Y Shaikh, Ewa Jankowska, George L Bakris, Stephan Von Haehling, Javed Butler
-
33m 53sPart 1 | Session 9 Meet the expert: Best practice recommendations for the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Clara Bonanad Lozano
-
34m 37sPart 1 | Session 10 Meet the expert: Hyperkalaemia in patients with heart failure – dreadful side effect or manageable condition? (Supported by an unrestricted educational grant from CSL Vifor) Javed Butler, Ileana L Piña
-
1h 2m 37sPart 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs Mitja Lainscak, Ambarish Pandey, Faiez Zannad, Justin Ezekowitz, Ileana L Piña, Harriette Van Spall
-
37m 5sPart 1 | Session 12 Meet the expert: Sex differences in advanced heart failure Andrew JS Coats, Aditi Nayak
-
1h 1m 4sPart 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF Antonio Ceriello, Naveed Sattar, Stefan Anker, Tammy Lyn Kindel, Andrew JS Coats, Jean-Philippe Minart
-
1h 2m 46sPart 2 | Session 1 Plenary Session 7: New technologies to manage your patients Vijay Chopra, Rishi Sethi, Friedrich Koehler, Jasper J Brugts, William T Abraham, Leor Perl
-
33m 44sPart 2 | Session 2 Meet the expert: Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients (Sponsored by an unrestricted grant from CVRx) Stefan Anker, Marat Fudim
-
1h 4m 11sPart 2 | Session 3 Plenary Session 8: New technologies to treat your patients Sajid Ansari, Fadi Jouhra, Marat Fudim, Johann Bauersachs, William T Abraham, Thomas Thum
-
1h 9sPart 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines Stefan Anker, Paul A Heidenreich, Antoni Bayés-Genís, Biykem Bozkurt, Gerasimos Filippatos, John GF Cleland
-
46m 45sPart 2 | Session 5 Satellite Symposim: Bridging the implementation gap in heart failure across the EF spectrum (Supported by an educational grant from AstraZeneca) John JV McMurray, Biykem Bozkurt, Giuseppe Rosano, Stephen J Greene
-
1h 1m 38sPart 2 | Session 6 Plenary Session 10: How to implement these GLS in ambulatory patients around the world Katherine Tuttle, Mehmet Birhan Yilmaz, Petar M Seferovic, Sivadasanpillai Harikrishnan, Yuhui Zhang, Magdy Abdelhamid , Clara Saldarriaga, Hiroyuki Tsutsui
-
30m 11sPart 2 | Session 7 Meet the expert: SGLT2 inhibition in patients with HFrEF ‒ a case-based discussion (Supported by an independent educational grant from Boehringer Ingelheim & Eli Lilly Alliance) Ewa Jankowska, Daniela Tomasoni
-
1h 1m 4sPart 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease Stephen J Greene, Mitja Lainscak, Gregg Stone, Horst Sievert, Harish Ramakrishna, Ralph Stephan von Bardeleben
-
31m 36sPart 2 | Session 9 Meet the expert: Management of tricuspid regurgitation in heart failure (Supported by an unrestricted educational grant from Edwards Lifesciences) Stefan Anker, Philipp Lurz
Overview
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day 1
Part 2
Day 2
Faculty Biographies
Ovidiu Chioncel
Professor of Cardiology, Head of ICCU
Dr Ovidiu Chioncel is Professor of Cardiology and Head of ICCU at the University of Medicine Carol Davila in Bucharest, Romania.
His clinical research interests include heart failure, cardiac imaging and emergency medicine.
Dr Chioncel has been involved in numerous clinical trials, and is Director of the Romanian Acute Heart Failure Syndrome registry (RO-AHFS), the National Registry of Acute Aortic Dissections (RENADA) and the National Coordinator of EORP/ESC-HF Registries.
Dr Ovdiu Chioncel is a Section Editor of Cardiac Failure Review.
Alanna Morris
Dr Alanna Morris is Assistant Professor of Medicine at the Department of Medicine, Emory University School of Medicine, US. Dr Morris' research interests include studying the importance of non-modifiable risk factors such as race and gender that may contribute to excess disease in high risk populations, and identifying the role of biomarkers of oxidative stress and endothelial dysfunction in patients with heart failure with reduced ejection fraction.
Shelley Zieroth
Director, Heart Failure and Heart Transplant Clinics
Dr Shelley Zieroth is Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St Boniface Hospital in Winnipeg, Canada. She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba.
She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. She is the Past President of the Canadian Heart Failure Society and Co-Chair of the Canadian Cardiovascular Society Heart Failure Guidelines. She is co-chair of Canada’s largest annual heart failure meeting, HF Update, and Past President of the Federation of Medical Women of Canada.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.
John R Teerlink
Director
Dr John R Teerlink is Director of the Heart Failure Program and of the Clinical Echocardiography Laboratory at the San Francisco Veterans Affairs Medical Center in San Francisco, California.
Dr Teerlink graduated from Swarthmore College with Highest Honors in Comparative Religious Studies and Cellular Biology. After receiving his medical degree from Harvard Medical School, he completed an internal medicine residency at the University of California San Francisco (UCSF).
Gerasimos Filippatos
Professor of Cardiology
Prof Gerasimos Filippatos is a Professor of Cardiology and Cardiologist at National and Kapodistrian University of Athens, Athens, GR.
He studied Medicine at the University of Patras, and earned his doctorate Cum Laude from the University of Athens.
Prof Filippatos is Past President of the Heart Failure Association (HFA) of the European Society of Cardiology and he has published over 600 articles in peer-reviewed journals and authored more than 30 book chapters.